Menu Search
Equities

Thermo Fisher Scientific Inc

TN8:BER

Thermo Fisher Scientific Inc

Actions
  • Price (EUR)491.45
  • Today's Change5.65 / 1.16%
  • Shares traded5.00
  • 1 Year change+11.29%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 07:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. It also provides proteomics solutions. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial and others. Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.

  • Revenue in USD (TTM)42.37bn
  • Net income in USD6.14bn
  • Incorporated1960
  • Employees122.00k
  • Location
    Thermo Fisher Scientific Inc168 Third AvenueWALTHAM 02451United StatesUSA
  • Phone+1 (781) 622-1000
  • Fax+1 (781) 622-1207
  • Websitehttps://www.thermofisher.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.